Showing results (151-160 of 25,849) with videos related to
Sort By:
Pageof 2,585
Microbial Drug Resistance (Larchmont, N.Y.)|December 20, 2019
Detection of High-Level Rifaximin Resistance in Enteric Bacteria by Agar ScreenPhilipp M P Baumert, Johannes Camp, Hannah Gölz, et al.Computer Applications in the Biosciences : CABIOS|February 1, 1993
Refined algorithm and computer program for calculating all non-negative fluxes admissible in steady states of biochemical reaction systems with or without some flux rates fixedR Schuster, S SchusterCancer Biology & Therapy|December 23, 2003
Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancerHiroyuki Matsubayashi, Noriyoshi Fukushima, Norihiro Sato, et al.Cancer Biology & Therapy|January 17, 2004
The genetics of FANCC and FANCG in familial pancreatic cancerCarmelle D Rogers, Michiel S van der Heijden, Kieran Brune, et al.Current Opinion in Rheumatology|August 18, 2004
Pain and osteoarthritis: new drugs and mechanismsBurkhard Hinz, Kay BruneJournal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology|May 19, 2005
Physiological properties of the gut lumen of terrestrial isopods (Isopoda: Oniscidea): adaptive to digesting lignocellulose?Martin Zimmer, Andreas BruneWiener Klinische Wochenschrift|March 27, 1999
[Specific COX-2 inhibitors: prospects of therapy with new analgesic and anti-inflammatory substances]B Hinz, K BruneApplied and Environmental Microbiology|October 3, 1999
Localization and in situ activities of homoacetogenic bacteria in the highly compartmentalized hindgut of soil-feeding higher termites (Cubitermes spp.)A Tholen, A BruneClinical and Experimental Rheumatology|November 7, 2001
Pharmacokinetic and pharmacodynamic aspects of the ideal COX-2 inhibitor: a pharmacologist's perspectiveK Brune, A NeubertDrugs of Today (Barcelona, Spain : 1998)|January 18, 2003
Herbal remedies for asthma treatment: between myth and realityIstvan Szelenyi, Kay BrunePageof 2,585